Tuesday 9 October 2012

Lemsip Cough Dry





1. Name Of The Medicinal Product



Lemsip Cough Dry


2. Qualitative And Quantitative Composition






















Active ingredients




Quantity/dose




Specification




Glycerol




0.25 ml




EP




Honey




500.00 mg




HSE




Citric acid monohydrate




25.00 mg




EP




Lemon oil terpeneless




0.0005 ml




BP




Syrup




3.75 ml




BP



3. Pharmaceutical Form



Linctus.



4. Clinical Particulars



4.1 Therapeutic Indications



For the symptomatic relief of dry tickly coughs and sore throats.



4.2 Posology And Method Of Administration



Route of administration - oral.



Adults and children over 12: Two 5ml spoonfuls, three or four times daily.



Children 1-12 years: One 5ml spoonful, three or four times daily.



No special dose is required for elderly patients.



4.3 Contraindications



Hypersensitivity to the active substance or any of the excipients.



Do not give to children under 1 year.



4.4 Special Warnings And Precautions For Use



Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.



This medicinal product contains small amounts of ethanol (alcohol), less than 100 mg per 5 ml.



Contains esters of parahydroxybenzoic acid which may cause allergic reactions (possibly delayed).



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None known.



4.6 Pregnancy And Lactation



As with many other medicines, this product should be avoided in the first three months of pregnancy and during lactation unless the benefits outweigh any risks; no significant problems have been reported in breast-fed infants from mothers taking this product.



4.7 Effects On Ability To Drive And Use Machines



None known.



4.8 Undesirable Effects



None known.



4.9 Overdose



Overdosage is unlikely but if it does occur then treatment consists of general supportive therapy and may include gastric lavage.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Glycerol, honey and syrup act as demulcents and provide a soothing medium for an irritated throat.



The citric acid monohydrate and the lemon oil, terpeneless both add to the sharpness of the product and enhance the flavour.



5.2 Pharmacokinetic Properties



Not applicable.



5.3 Preclinical Safety Data



No preclinical findings of relevance have been reported.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Ethanol (96%), Nipasept sodium and water.



6.2 Incompatibilities



None known.



6.3 Shelf Life



Three years.



6.4 Special Precautions For Storage



Store below 25°C.



6.5 Nature And Contents Of Container



Amber glass bottles with a polypropylene cap with a polyethylene tamper-evident band with expanded polyethylene wad. Pack sizes: 100 ml and 200 ml (100 ml is currently sold).



6.6 Special Precautions For Disposal And Other Handling



Oral administration.



ADMINISTRATIVE DATA


7. Marketing Authorisation Holder



Reckitt Benckiser Healthcare (UK) Limited,



Dansom Lane,



Hull,



HU8 7DS.



8. Marketing Authorisation Number(S)



PL 0063/0038.



9. Date Of First Authorisation/Renewal Of The Authorisation



24th April, 1995.



10. Date Of Revision Of The Text



08/07/2011




No comments:

Post a Comment